Inhibrx Inc.
13F holders, Q2 2024 (June 30)2holders −124
0new positions
55sold out
$34.94avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Inhibrx Inc. in their 13F filings, down 124 from Q1 2024. 0 opened new positions and 55 sold out. The largest holders were DekaBank Deutsche Girozentrale ($928K) and Osaic Holdings, Inc. ($228K).
- Company
- Inhibrx Inc.
- CUSIP
- 45720L107
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 55 | $262.3M |
All 13F filers, Q1 2024 → Q2 2024: 7,509,821 shares sold, net −7,509,821 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| DekaBank Deutsche Girozentrale | 0.00% | No change | 26,400 | $928K |
| Osaic Holdings, Inc. | 0.00% | Reduce -7.4% | 6,690 | $228K |
"% of holder's portfolio" is INHIBRX INC's weight in each manager's 13F, not the share of Inhibrx Inc. the manager owns.